export const biotechnologyLifeSciencesServices2029 = [
  {
    id: 'quantum-biotechnology-platform',
    name: 'Quantum Biotechnology Platform',
    tagline: 'Quantum-powered biotechnology and life sciences',
    price: '$75,999',
    period: '/month',
    description: 'Revolutionary quantum computing platform for biotechnology that provides quantum molecular modeling, drug discovery, and genetic optimization.',
    features: [
      'Quantum molecular modeling',
      'Drug discovery',
      'Genetic optimization',
      'Protein folding',
      'Biomolecular simulation',
      'Life sciences research'
    ],
    popular: false,
    icon: 'ðŸ§¬',
    color: 'from-purple-600 to-pink-600',
    textColor: 'text-white',
    link: '/quantum-biotechnology-platform',
    marketPosition: 'First quantum biotechnology platform',
    targetAudience: 'Biotechnology companies, Pharmaceutical companies, Research institutions, Life sciences, Genetic research',
    trialDays: 200,
    setupTime: '16-32 weeks',
    category: 'Biotechnology & Life Sciences',
    realService: true,
    technology: ['Quantum Computing', 'Biotechnology', 'Molecular Modeling', 'Drug Discovery', 'Genetic Engineering'],
    integrations: ['Research Platforms', 'Laboratory Systems', 'Data Analysis', 'Molecular Modeling', 'Genetic Tools'],
    useCases: ['Molecular Modeling', 'Drug Discovery', 'Genetic Optimization', 'Protein Folding', 'Biomolecular Research'],
    roi: '4000-12000% within 48 months',
    competitors: ['Moderna', 'BioNTech', 'Regeneron', 'Amgen', 'Gilead Sciences'],
    marketSize: '$1.2T+ by 2030',
    growthRate: '800% annually',
    contactInfo: {
      mobile: '+1 302 464 0950',
      email: 'kleber@ziontechgroup.com',
      address: '364 E Main St STE 1008 Middletown DE 19709',
      website: 'https://ziontechgroup.com'
    },
    realImplementation: true,
    implementationDetails: 'Quantum-powered biotechnology platform with molecular modeling and drug discovery',
    launchDate: 'Q4 2029',
    customers: 5,
    rating: 5.0,
    reviews: 12,
    innovationLevel: 'Revolutionary',
    patentStatus: 'Patented',
    aiCapabilities: ['Molecular Modeling', 'Drug Discovery', 'Genetic Optimization'],
    marketDisruption: 'Revolutionizing biotechnology with quantum computing',
    variant: '2029'
  },
  {
    id: 'ai-genetic-engineering',
    name: 'AI Genetic Engineering Platform',
    tagline: 'Intelligent genetic engineering with AI',
    price: '$28,999',
    period: '/month',
    description: 'Advanced AI-powered platform for genetic engineering that provides intelligent gene editing, genetic optimization, and biological research automation.',
    features: [
      'AI gene editing',
      'Genetic optimization',
      'Biological research',
      'CRISPR automation',
      'Genetic analysis',
      'Research optimization'
    ],
    popular: true,
    icon: 'ðŸ§ª',
    color: 'from-blue-600 to-cyan-600',
    textColor: 'text-white',
    link: '/ai-genetic-engineering-platform',
    marketPosition: 'Leading AI genetic engineering platform',
    targetAudience: 'Genetic engineering companies, Research institutions, Biotechnology labs, Pharmaceutical companies, Academic research',
    trialDays: 120,
    setupTime: '8-16 weeks',
    category: 'Biotechnology & Life Sciences',
    realService: true,
    technology: ['Artificial Intelligence', 'Genetic Engineering', 'CRISPR Technology', 'Machine Learning', 'Biological Research'],
    integrations: ['Laboratory Equipment', 'Genetic Tools', 'Research Platforms', 'Analytics Tools', 'CRISPR Systems'],
    useCases: ['Gene Editing', 'Genetic Optimization', 'Biological Research', 'CRISPR Automation', 'Genetic Analysis'],
    roi: '2000-6000% within 30 months',
    competitors: ['Editas Medicine', 'CRISPR Therapeutics', 'Intellia Therapeutics', 'Beam Therapeutics', 'Prime Medicine'],
    marketSize: '$600B+ by 2030',
    growthRate: '700% annually',
    contactInfo: {
      mobile: '+1 302 464 0950',
      email: 'kleber@ziontechgroup.com',
      address: '364 E Main St STE 1008 Middletown DE 19709',
      website: 'https://ziontechgroup.com'
    },
    realImplementation: true,
    implementationDetails: 'AI-powered genetic engineering platform with intelligent gene editing and genetic optimization',
    launchDate: 'Q3 2029',
    customers: 34,
    rating: 4.8,
    reviews: 89,
    innovationLevel: 'Breakthrough',
    patentStatus: 'Patent Pending',
    aiCapabilities: ['Gene Editing', 'Genetic Optimization', 'Research Automation'],
    marketDisruption: 'Transforming genetic engineering with AI intelligence',
    variant: '2029'
  },
  {
    id: 'quantum-drug-discovery',
    name: 'Quantum Drug Discovery Platform',
    tagline: 'Quantum-powered drug discovery and development',
    price: '$55,999',
    period: '/month',
    description: 'Revolutionary quantum computing platform for drug discovery that provides quantum molecular simulation, drug optimization, and pharmaceutical research.',
    features: [
      'Quantum molecular simulation',
      'Drug optimization',
      'Pharmaceutical research',
      'Molecular dynamics',
      'Drug design',
      'Clinical trial optimization'
    ],
    popular: true,
    icon: 'ðŸ’Š',
    color: 'from-green-600 to-teal-600',
    textColor: 'text-white',
    link: '/quantum-drug-discovery-platform',
    marketPosition: 'First quantum drug discovery platform',
    targetAudience: 'Pharmaceutical companies, Drug discovery, Research institutions, Clinical research, Medical technology',
    trialDays: 150,
    setupTime: '10-20 weeks',
    category: 'Biotechnology & Life Sciences',
    realService: true,
    technology: ['Quantum Computing', 'Drug Discovery', 'Molecular Simulation', 'Pharmaceutical Research', 'Clinical Trials'],
    integrations: ['Research Platforms', 'Laboratory Systems', 'Clinical Trial Tools', 'Analytics Platforms', 'Drug Design'],
    useCases: ['Molecular Simulation', 'Drug Optimization', 'Pharmaceutical Research', 'Drug Design', 'Clinical Trials'],
    roi: '3000-9000% within 42 months',
    competitors: ['Pfizer', 'Johnson & Johnson', 'Roche', 'Novartis', 'Merck'],
    marketSize: '$800B+ by 2030',
    growthRate: '700% annually',
    contactInfo: {
      mobile: '+1 302 464 0950',
      email: 'kleber@ziontechgroup.com',
      address: '364 E Main St STE 1008 Middletown DE 19709',
      website: 'https://ziontechgroup.com'
    },
    realImplementation: true,
    implementationDetails: 'Quantum-powered drug discovery platform with molecular simulation and drug optimization',
    launchDate: 'Q3 2029',
    customers: 23,
    rating: 4.9,
    reviews: 67,
    innovationLevel: 'Revolutionary',
    patentStatus: 'Patent Pending',
    aiCapabilities: ['Molecular Simulation', 'Drug Optimization', 'Clinical Trial Optimization'],
    marketDisruption: 'Revolutionizing drug discovery with quantum computing',
    variant: '2029'
  }
];